Cell Cycle Proteins and Retinal Degeneration: Evidences of New Potential Therapeutic Targets

被引:5
|
作者
Arsenijevic, Yvan [1 ]
机构
[1] Univ Lausanne, Dept Ophthalmol, Unit Gene Therapy & Stem Cell Biol, 15 Av France, CH-1004 Lausanne, Switzerland
来源
RETINAL DEGENERATIVE DISEASES: MECHANISMS AND EXPERIMENTAL THERAPY | 2016年 / 854卷
关键词
Retinal degeneration; Alzheimer's disease; Parkinson's disease; CDK5; BMI1; Cell cycle; Neuroprotection; Stroke; CDK4; DEPENDENT KINASES; DEATH; NEURODEGENERATION; TOXICITY; NEURONS; PATHWAY;
D O I
10.1007/978-3-319-17121-0_49
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
During different forms of neurodegenerative diseases, including the retinal degeneration, several cell cycle proteins are expressed in the dying neurons from Drosophila to human revealing that these proteins are a hallmark of neuronal degeneration. This is true for animal models of Alzheimer's, and Parkinson's diseases, Amyotrophic Lateral Sclerosis and for Retinitis Pigmentosa as well as for acute injuries such as stroke and light damage. Longitudinal investigation and loss-of-function studies attest that cell cycle proteins participate to the process of cell death although with different impacts, depending on the disease. In the retina, inhibition of cell cycle protein action can result to massive protection. Nonetheless, the dissection of the molecular mechanisms of neuronal cell death is necessary to develop adapted therapeutic tools to efficiently protect photoreceptors as well as other neuron types.
引用
收藏
页码:371 / 377
页数:7
相关论文
共 50 条
  • [21] CircRNA and Stroke: New Insight of Potential Biomarkers and Therapeutic Targets
    Chen, Xiao-Ling
    Tan, Quan-Dan
    Chen, Ke-Jie
    Zheng, Dan-Ni
    Deng, Hong-Wei
    He, Song
    Mao, Feng-Kai
    Hao, Jun-Li
    Le, Wei-Dong
    Yang, Jie
    NEUROCHEMICAL RESEARCH, 2024, 49 (03) : 557 - 567
  • [22] New inhibitors of poly(ADPribose) polymerase and their potential therapeutic targets
    Cosi, C
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2002, 12 (07) : 1047 - 1071
  • [23] MiRNAs as new potential biomarkers and therapeutic targets in brain metastasis
    Beylerli, Ozal
    Shi, Huaizhang
    Begliarzade, Sema
    Shumadalova, Alina
    Ilyasova, Tatiana
    Sufianov, Albert
    NON-CODING RNA RESEARCH, 2024, 9 (03): : 678 - 686
  • [24] The CDK inhibitors: potential targets for therapeutic stem cell manipulations?
    M J Boyer
    T Cheng
    Gene Therapy, 2008, 15 : 117 - 125
  • [25] Molecular Mechanisms Mediating Diabetic Retinal Neurodegeneration: Potential Research Avenues and Therapeutic Targets
    Harshini Chakravarthy
    Vasudharani Devanathan
    Journal of Molecular Neuroscience, 2018, 66 : 445 - 461
  • [26] Cell Death Pathways in Mutant Rhodopsin Rat Models Identifies Genotype-Specific Targets Controlling Retinal Degeneration
    Viringipurampeer, Ishaq A.
    Gregory-Evans, Cheryl Y.
    Metcalfe, Andrew L.
    Bashar, Emran
    Moritz, Orson L.
    Gregory-Evans, Kevin
    MOLECULAR NEUROBIOLOGY, 2019, 56 (03) : 1637 - 1652
  • [27] NLRP3 and autophagy in retinal ganglion cell inflammation in age-related macular degeneration: potential therapeutic implications
    Wang, Xiao-Li
    Gao, Yun-Xia
    Yuan, Qiong-Zhen
    Zhang, Ming
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2024, 17 (08) : 1531 - 1544
  • [28] Interaction of AR and iNOS in lens epithelial cell: A new pathogenesis and potential therapeutic targets of diabetic cataract
    Li, Xue
    Liu, Wenping
    Huang, Xinduo
    Xiong, Jianping
    Wei, Xiaoyong
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2017, 615 : 44 - 52
  • [29] Restorative potential of ciliary body cells in a retinal ganglion cell degeneration model
    Fernando Lucas-Ruiz
    Marta Fernández-Nogales
    Francisco J. Valiente-Soriano
    Macarena Herrera
    Francisco M. Nadal-Nicolás
    Marta Agudo-Barriuso
    Eloisa Herrera
    Scientific Reports, 15 (1)
  • [30] Interplay between cancer cell cycle and metabolism: Challenges, targets and therapeutic opportunities
    Roy, Debmalya
    Sheng, Gao Ying
    Herve, Semukunzi
    Carvalho, Evandro
    Mahanty, Arpan
    Yuan, Shengtao
    Sun, Li
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 89 : 288 - 296